Northern Trust’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$307K Sell
1,257
-220
-15% -$49.1K ﹤0.01% 3775
2026
Q2
$300K Buy
+1,477
New +$278K ﹤0.01% 3807
2026
Q1
– Sell
-1,100
Closed -$208K – 4410
2025
Q4
$208K Sell
1,100
-1,020
-48% -$189K ﹤0.01% 3976
2025
Q3
$351K Buy
+2,120
New +$346K ﹤0.01% 3776
2022
Q2
– Sell
-2,850
Closed -$462K – 4750
2022
Q1
$462K Hold
2,850
– – ﹤0.01% 3770
2021
Q4
$540K Sell
2,850
-257
-8% -$49.6K ﹤0.01% 3779
2021
Q3
$628K Sell
3,107
-360
-10% -$75.6K ﹤0.01% 3682
2021
Q2
$699K Sell
3,467
-187
-5% -$34.8K ﹤0.01% 3611
2021
Q1
$641K Buy
3,654
+300
+9% +$54.2K ﹤0.01% 3743
2020
Q4
$569K Buy
3,354
+2,053
+158% +$338K ﹤0.01% 3691
2020
Q3
$211K Buy
+1,301
New +$212K ﹤0.01% 3810

Other funds holding BBH

Northern Trust's BBH Position: Q3 2026 in Review

Northern Trust reduced its VanEck Biotech ETF (BBH) stake by 15% in Q3 2026, selling an estimated $49.1K and leaving 1,257 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #3775.

Northern Trust first reported a position in BBH in Q3 2020 and has held it in 11 quarters since. The position peaked at $699K in Q2 2021. 123 funds tracked by Wall St. Rank hold BBH as of Q3 2026.

  • Northern Trust held 1,257 shares of VanEck Biotech ETF worth $307K as of Q3 2026.
  • Northern Trust sold 220 VanEck Biotech ETF shares in Q3 2026, an estimated $49.1K.
  • VanEck Biotech ETF made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #3775 holding.
  • Northern Trust first reported a position in VanEck Biotech ETF in Q3 2020 and has held it in 11 quarters since.
  • Northern Trust's VanEck Biotech ETF position peaked at $699K in Q2 2021.
  • 123 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2026.

Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.